Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 117Unknown 51Recruiting 26Active not recruiting 14Not yet recruiting 12Terminated 11Withdrawn 7Enrolling by invitation 2Suspended 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 2

Conditions

Breast Neoplasms 58Neoplasms 52Colorectal Neoplasms 32Prostatic Neoplasms 29Lung Neoplasms 21Stomach Neoplasms 17Carcinoma, Non-Small-Cell Lung 16Carcinoma, Hepatocellular 16Uterine Cervical Neoplasms 13Anxiety Disorders 13Colonic Neoplasms 11Brain Neoplasms 11Pancreatic Neoplasms 10Lymphoma, Follicular 9Leukemia, Myeloid, Acute 8Head and Neck Neoplasms 8Barrett Esophagus 8Urinary Bladder Neoplasms 7Rectal Neoplasms 7Esophageal Squamous Cell Carcinoma 7Esophageal Neoplasms 7Disease 7Diabetes Mellitus 7Cholangiocarcinoma 7Sarcoma 6Recurrence 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Pain 6Ovarian Neoplasms 6Motor Activity 6

Interventions

Aftercare 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × OTHER × Carcinoma, Basal Cell × Clear all
NCT07347392 2026-01-16

DOSCA-2

University of Aarhus

Enrolling by invitation
2,900 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT07311070 2026-01-06

Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue

Mashhad University of Medical Sciences

Phase 3 Enrolling by invitation
20 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡